M
Maria A. Rocca
Researcher at Vita-Salute San Raffaele University
Publications - 647
Citations - 29881
Maria A. Rocca is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Multiple sclerosis & Magnetic resonance imaging. The author has an hindex of 83, co-authored 556 publications receiving 25283 citations. Previous affiliations of Maria A. Rocca include University at Buffalo & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Selective diffusion changes of the visual pathways in patients with migraine : a 3-T tractography study
Maria A. Rocca,Elisabetta Pagani,Bruno Colombo,Paola Tortorella,Andrea Falini,G. Comi,Massimo Filippi +6 more
TL;DR: DT tractography reveals OR changes in MA patients that might represent a phenotypic biomarker of the disease given the lack of correlation with clinical and structural MRI metrics.
Journal ArticleDOI
MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis.
Paola Tortorella,Maria A. Rocca,Domenico M. Mezzapesa,Angelo Ghezzi,Loredana Lamantia,Giancarlo Comi,Massimo Filippi +6 more
TL;DR: This study confirms the paucity of the ‘occult’ brain tissue damage in patients with earlyonset MS and suggests that in these patients GM is spared by the disease process and that NAWM changes are likely to be secondary to Wallerian degeneration of fibers passing through macroscopic lesions.
Journal ArticleDOI
Imaging resting state brain function in multiple sclerosis
TL;DR: This review describes the major findings obtained in MS patients at different clinical stages using resting state fMRI, and discusses how the use of fMRI techniques may improve the ability to identify novel biomarkers useful in the context of the diagnostic work up, establishing prognosis and monitoring treatment.
Journal ArticleDOI
Conventional MRI in multiple sclerosis.
Massimo Filippi,Maria A. Rocca +1 more
TL;DR: Technical development in acquisition and postprocessing, as well as the introduction of high‐field magnets in the clinical arena, are likely to increase the understanding of disease pathobiology, mainly through an increased ability to quantify the extent of gray matter damage.
Journal ArticleDOI
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases
A. Ghezzi,Carlo Pozzilli,L.M.E. Grimaldi,Lucia Moiola,Vincenzo Bresciamorra,Alessandra Lugaresi,Giacomo Lus,Francesca Rinaldi,Maria A. Rocca,Maria Trojano,A. Bianchi,G. Comi,Massimo Filippi +12 more
TL;DR: A strong suppression of disease activity was observed in the majority of patients during the follow-up and natalizumab was well tolerated in all patients.